Literature DB >> 19217286

N-Benzyl-indolo carboxylic acids: Design and synthesis of potent and selective adipocyte fatty-acid binding protein (A-FABP) inhibitors.

Tjeerd Barf1, Fredrik Lehmann, Kristin Hammer, Saba Haile, Eva Axen, Carmen Medina, Jonas Uppenberg, Stefan Svensson, Lena Rondahl, Thomas Lundbäck.   

Abstract

Small molecule inhibitors of adipocyte fatty-acid binding protein (A-FABP) have gained renewed interest following the recent publication of pharmacologically beneficial effects of such inhibitors. Despite the potential utility of selective A-FABP inhibitors within the fields of metabolic disease, inflammation and atherosclerosis, there are few examples of useful A-FABP inhibitors in the public domain. Herein, we describe the optimization of N-benzyl-tetrahydrocarbazole derivatives through the use of co-crystal structure guided medicinal chemistry efforts. This led to the identification of a potent and selective class of A-FABP inhibitors as illustrated by N-benzyl-hexahydrocyclohepta[b]indole 30.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19217286     DOI: 10.1016/j.bmcl.2009.01.084

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  21 in total

1.  Structural analysis of ibuprofen binding to human adipocyte fatty-acid binding protein (FABP4).

Authors:  Javier M González; S Zoë Fisher
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-01-28       Impact factor: 1.056

2.  Divergent Reactivity of Rhodium(I) Carbenes Derived from Indole Annulations.

Authors:  Xiaoxun Li; Hui Li; Wangze Song; Po-Sen Tseng; Lingyan Liu; Ilia A Guzei; Weiping Tang
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-07       Impact factor: 15.336

3.  Interaction Analysis of FABP4 Inhibitors by X-ray Crystallography and Fragment Molecular Orbital Analysis.

Authors:  Uno Tagami; Kazutoshi Takahashi; Shunsuke Igarashi; Chieko Ejima; Tomomi Yoshida; Sen Takeshita; Wataru Miyanaga; Masayuki Sugiki; Munetaka Tokumasu; Toshihiro Hatanaka; Tatsuki Kashiwagi; Kohki Ishikawa; Hiroshi Miyano; Toshimi Mizukoshi
Journal:  ACS Med Chem Lett       Date:  2016-02-16       Impact factor: 4.345

4.  Benzbromarone, an old uricosuric drug, inhibits human fatty acid binding protein 4 in vitro and lowers the blood glucose level in db/db mice.

Authors:  Hai-yan Cai; Ting Wang; Jian-chun Zhao; Peng Sun; Gui-rui Yan; Hai-peng Ding; Ying-xia Li; He-yao Wang; Wei-liang Zhu; Kai-xian Chen
Journal:  Acta Pharmacol Sin       Date:  2013-09-30       Impact factor: 6.150

5.  Small-molecule inhibitors of FABP4/5 ameliorate dyslipidemia but not insulin resistance in mice with diet-induced obesity.

Authors:  Hong Lan; Cliff C Cheng; Timothy J Kowalski; Ling Pang; Lixin Shan; Cheng-Chi Chuang; James Jackson; Alberto Rojas-Triana; Loretta Bober; Li Liu; Johannes Voigt; Peter Orth; Xianshu Yang; Gerald W Shipps; Joseph A Hedrick
Journal:  J Lipid Res       Date:  2011-02-04       Impact factor: 5.922

Review 6.  Function of lipid binding proteins of parasitic helminths: still a long road.

Authors:  Jose F Lombardo; Jorge L Pórfido; Martín S Sisti; A Nahili Giorello; Santiago Rodríguez; Betina Córsico; Gisela R Franchini
Journal:  Parasitol Res       Date:  2022-02-16       Impact factor: 2.289

7.  Rhodium- and platinum-catalyzed [4+3] cycloaddition with concomitant indole annulation: synthesis of cyclohepta[b]indoles.

Authors:  Dongxu Shu; Wangze Song; Xiaoxun Li; Weiping Tang
Journal:  Angew Chem Int Ed Engl       Date:  2013-02-10       Impact factor: 15.336

Review 8.  Metabolic functions of FABPs--mechanisms and therapeutic implications.

Authors:  Gökhan S Hotamisligil; David A Bernlohr
Journal:  Nat Rev Endocrinol       Date:  2015-08-11       Impact factor: 43.330

9.  Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs.

Authors:  William T Berger; Brian P Ralph; Martin Kaczocha; Jing Sun; Trent E Balius; Robert C Rizzo; Samir Haj-Dahmane; Iwao Ojima; Dale G Deutsch
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

10.  Lipid chaperones and metabolic inflammation.

Authors:  Masato Furuhashi; Shutaro Ishimura; Hideki Ota; Tetsuji Miura
Journal:  Int J Inflam       Date:  2011-10-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.